DEPDC1 and triple-negative breast carcinoma: Further, we counted the expression of DEPDC1 in triple-negative breast cancer (TNBC) which was a highly malignant breast cancer, and observed that its expression in TNBC even higher (p < 0.0001, Figure 2F).